Recombinant human erythropoietin in severe anaemia: issues of dosing and duration. (avaa uuden ikkunan)

Charles A, Purtill M, Napolitano LM.

Lähde‎: Anaesth Intensive Care 2006;34(6):793-6.

Arkistoitu‎: PubMed 17183900

https://www.ncbi.nlm.nih.gov/pubmed/17183900 (avaa uuden ikkunan)

Intravenous ferric carboxymaltose versus standard care in the management of postoperative anaemia: a prospective, open-label, randomised controlled trial. (avaa uuden ikkunan)

Khalafallah AA, Yan C, Al-Badri R, Robinson E, Kirkby BE, Ingram E, Gray Z, Khelgi V, Robertson IK, Kirkby BP.

Lähde‎: Lancet Haematol 2016;3(9):e415-25.

Arkistoitu‎: PubMed 27570088

DOI‎: 10.1016/S2352-3026(16)30078-3

https://www.ncbi.nlm.nih.gov/pubmed/27570088 (avaa uuden ikkunan)